Pre-surgical studies allow study of the partnership between mutations and response of oestrogen receptor-positive (ER+) breast cancer to aromatase inhibitors (AIs) but have already been limited to little biopsies. connected with poor response. We conclude that multiple biopsies are crucial for assured mutational profiling of ER+ breasts tumor and mutations are connected with level of… Continue reading Pre-surgical studies allow study of the partnership between mutations and response